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Abstract 
 
Recent changes in preoperative fasting guidelines have resulted in the development of 
preoperative carbohydrate drinks.  Almost all research to date has examined the 
immediate/early postoperative metabolic and physiological effects, concluding 
beneficial clinical outcomes post surgery. The aim of this study was to test the 
hypothesis that preoperative carbohydrate loading results in longer term improvements 
in wellbeing, sustained return of postoperative physical function and better retention of 
muscle mass and nutritional status at a later (and potentially more clinically relevant) 
stage in the postoperative recovery period.  This double-blinded placebo controlled 
randomised control trial took place at Salford Royal NHS Foundation Trust between 1st 
April 2008 and 31st January 2010.  10 males and 4 females, with a median age of 65.5 
years, were included in the study and these were all listed for potentially curative 
colorectal cancer surgery.  Each participant was assessed preoperatively, daily 
throughout their hospital admission and then at 30 days post surgery.  Assessments 
included anthropometric measurements, analysis of dietary intake, physical activity and 
an evaluation of pain and well-being. 
 
The results showed that carbohydrate loading had no significant effects on 
anthropometric, dietary, physical or well-being parameters.  However it was seen that 
pain scores in those patients who received carbohydrate loading were significantly 
lower (p=0.017) 30 days post surgery than those who received the placebo drinks.  The 
trial was a pilot study and has shown that further research is needed to determine 
whether carbohydrate loading may have long-term clinical benefits. 
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1. Introduction 
 
 
Surgery can have a significant impact on nutritional status, from preoperative 
restrictions on oral intake, the stress of the procedure to the postoperative period when 
nutritional intake may be sub-optimal.  This clearly has an impact on surgical 
outcomes, particularly if energy demands are raised prior to the surgery due to the 
underlying condition (Hyltander, Drott, Korner, Sandstrom and Lundholm, 1991). 
 
It is well-known that the systemic response to surgery brings about a change in 
metabolism, and this response to stress is divided into three phases: 
1. The ‘ebb’ phase  
2. The ‘flow’ phase (also known as recovery phase) 
3. The anabolic phase. 
 
• The ebb phase lasts between 12-24 hours after surgery and is characterized by 
a decrease in the basal metabolic rate, along with a reduced cardiac output and 
temperature. Energy is provided in the form of hepatic glycogen stores.  (Van 
Cromphaut, 2009) 
 
• The flow phase represents the catabolic period, of which hypermetabolism and 
increased nitrogen losses are key indicators.  Body temperature also increases 
at this time (Van Cromphaut, 2009).  This phase can range in length, depending 
on the extent of the trauma; in uncomplicated colorectal surgery it would 
typically last between 2-4 weeks after surgery (Thorell, Efendic, Gutniak, 
Haggmark and Ljungqvist, 1994).  It has been theorised that this stress 
response evolved to allow animals to survive injury by the provision of energy 
from the catabolism of their body stores (Desborough, 2000).  
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• It is during the anabolic phase that tissue breakdown can be reversed and 
nitrogen balance becomes positive, as the basal metabolic rate slows down and 
catabolic mediators reduce in circulation.   This phase can last from weeks to 
months. 
 
During the flow phase of the systemic stress response to surgery the metabolic rate 
increases and therefore energy demand is increased, if patients are fasted prior to 
undergoing surgery then glycogen stores are limited and therefore fat and protein are 
used in order to supply energy and this comes about through gluconeogenesis.  Lipids, 
which consist of fatty acid molecules joined to molecules of glycerol, are hydrolysed to 
release glycerol and additionally proteins are catabolised into their component amino 
acids.  These two substrates enter energy metabolism pathways as pyruvate or acetyl 
CoA intermediates, where they may be oxidised to produce adenosine triphosphate 
(ATP). This process is simplified in figure 1.       
 
Carbohydrate    Protein     Fat 
 
 
 
    Glucose    Amino Acids    Fatty acids 
 
   
 
Pyruvate       
Acetyl CoA 
 
     
Oxaloacetate 
       
        
 
Krebs cycle  ATP (energy) 
 
Figure 1. Energy production via the pathway of gluconeogensis 
 
The stress brought about by surgery involves an immune response whereby proteins 
are produced which bind to receptors on target cells with the role of signalling to other 
cells and marking the site of trauma (Giannoudis, Dinopoulos, Chalidis and Hall, 2006).  
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These proteins are named cytokines and include interleukin 6 (IL6) and tumour 
necrosis factor (TNF) which are believed to mediate insulin resistance (Witasp et al., 
2009).  Furthermore, the stress hormones catecholamines, cortisol and growth 
hormone are released (Witasp, Nordfors, Schalling, Nygren, Ljungqvist & Thorell , 
2009).  Catecholamines are also known to inhibit insulin release, and therefore the net 
result of the immune response is insulin resistance, resulting in reduced glucose 
uptake and thus increased blood glucose levels.  To further exacerbate this condition, 
in response to the decreased insulin:glucagon ratio, gluconeogensis is stimulated 
(Nygren, Thorell, Efendic, Nair and Ljungqvist, 1997), resulting in hyperglycaemia.  In 
addition to this, hepatic protein synthesis increases to produce acute phase proteins 
therefore increasing protein requirements (Giannoudis et al, 2006). 
 
Hyperglycaemia has been proven to have a negative effect on wound healing and to 
suppress immunity (Ljungqvist, Nygren, Soop and Thorell, 2005).  Moreover studies 
which involve regulated glucose levels in metabolically stressed patients have been 
shown to reduce mortality and morbidity in both the early (Van den Berghe et al., 2001) 
and late postoperative periods (Hill, Douglas and Schroeder, 1993).  There are a 
number of theories as to how hyperglycaemia induces this negative effect and 
increases complications.   One theory is that those cells which do not require insulin for 
glucose uptake become overloaded with glucose due to the high extracellular levels, an 
effect that is further exacerbated by cytokines and results in glucose toxicity (Ljungqvist 
et al., 2005).  It is proposed that this excess glucose overloads the mitochondria as it 
enters the Krebs cycle and results in an increased level of reactive oxidative species, 
thus altering mitochondria function and structure (Ljungqvist et al., 2005).   This insulin 
resistance, and associated hyperglycaemia is most pronounced immediately post 
surgery, however it can last up to 20 days after the operation (Thorell et al., 1994).   
 
Understanding this response enabled research into measures to limit insulin resistance 
and its associated detrimental effects.  Perioperative intravenous infusions of glucose 
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and insulin were shown to greatly attenuate postoperative insulin resistance, 
(Ljungqvist, Thorell, Gutniak, Haggmark and, Efendic, 1994; Nygren et al., 1998a; 
Brandi et al., 1990) and thus reduce nitrogen losses, (Crowe, Dennison and Royle, 
1984), as they increase hepatic glycogen content during surgery.  However, such 
methods can be highly labour intensive and difficult to administer safely, as frequent 
monitoring of blood glucose levels and insulin infusions is required.  Furthermore, as 
the glucose solution needed to be a moderately high osmolality then this caused 
vascular irritation to some patients.  A previous study demonstrated a significant 
decrease in residual gastric volume at the time of anaesthesia, measured by suction, 
when water was given two hours prior to surgery (Agarwal, Chari and Singh 1989).  
This allowed for research into the use of oral provisions to potentially reduce 
postoperative insulin resistance.  Nygren et al., (1995) used radioactively labelled 
carbohydrate-rich drinks and measured gastric emptying using a gamma camera, 
finding that after 90 minutes of consumption, the stomach was empty.  Historically 
preparation for major surgery had involved a period of fasting for 12-16 hours in order 
to ensure complete gastric emptying; this was due to evidence that showed 
anaesthesia could lead to a loss of muscle tone in the upper airway and oesophagus 
(Hillman, Platt and Eastwood, 2003), thereby increasing the risk of passive 
regurgitation or vomiting.  However this study demonstrated that gastric volumes and 
pH are within safe limits when clear fluids are given up to two hours prior to surgery, 
thus concluding that the traditional practice of complete prolonged fasting prior to 
surgery is neither necessary nor desirable.   
  
 
In response to this The Association of Anaesthetists of Great Britain and Ireland 
(AAGBI) published amended guidelines in 2001 (AAGBI, 2001) on the preparation of 
patients for surgery, which recommend the following minimum fasting periods: 
• Six hours for solid food, infant formula, or other milk 
•  Four hours for breast milk 
16 
 
•  Two hours for clear non-particulate and non-carbonated fluids 
 
This change in practice enabled further research to be carried out into the feasibility of 
carbohydrate drinks as an alternative to intravenous glucose infusion and indeed 
Nygren et al., (1998b) demonstrated that post-operative catabolism and thus insulin 
sensitivity were reduced by administration of a carbohydrate drink prior to surgery.  
There were of course limitations to this study as there were only seven participants in 
each group, which may have explained why significant results were not always found.  
Additionally the groups appeared not to be well matched, as pre-operative insulin 
sensitivity was higher in the fasted group than the intervention group, which could have 
affected the post-operative results.  Furthermore, the groups were not matched for 
length of surgery, and this has been shown to independently affect insulin sensitivity 
(Thorell, Efendic, Gutniak, Haggmark and Ljungqvist, 1993).  However further studies 
supported the findings of reduced postoperative insulin resistance when preoperative 
fasting was avoided (Soop, Nygren, Myrenfors, Thorell and Ljungqvist, 2001; Kaska et 
al., 2010).  Additionally the timing of the carbohydrate drink was considered and it was 
shown that when provided in the morning, insulin action, and thus glucose disposal, 
increased by approximately 50% for three hours following the drink administration.  
However, when the carbohydrate drink was provided in the evening, insulin action was 
not affected (Svanfeldt et al., 2005).  This suggests that the morning carbohydrate drink 
is of most significance as it changes the metabolic state to that of normal daytime and 
not the overnight fasted state.  A disadvantage of Svanfeldt et al. (2005) however was 
its sample size, with a total of only six participants. It should also be considered that the 
study was unblinded and thus could have introduced bias from the participants and 
observers, but the authors argued that the study design did not enable it be blinded. It 
could be suggested that the provision of water, with sweetener to match the taste of the 
carbohydrate drink, could have been used in the controls. 
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So it becomes clear that whilst the evidence has some limitations, overall carbohydrate 
drinks were shown to reduce postoperative insulin resistance.  This is because the 
glucose monomers provided preoperatively are bonded together during glycogenesis 
and stored in the form of glycogen within the liver.  During and post surgery when 
energy demands are increased, these glycogen stores are broken down by 
glycogenolysis (figure 2).  This therefore increases glucose supplies, which combined 
with a decrease in insulin resistance can potentially result in improved peripheral 
glucose uptake and oxidation (Nygren, 2006) and decreased glucose production 
(Ljungqvist, 2009).  This effect could last for up to 3 days post-operatively (Soop, 
Carlson, Hopkinson, Clarke, Thorell, Nygren & Ljungqvist, 2004).   
 
Glycogen 
 
 
 
phosphorylase 
  
 
 
 
Glycogen + glucose-1-phosphate 
      
 
 
phosphoglucomutase 
 
 
 
 
Glucose-6-phosphate 
 
 
 
glucose-6-phosphatase 
 
 
 
 
      Glucose 
 
Figure 2.  Energy production from glycogen via glycogenolysis 
 
 
This research led to the development of commercial carbohydrate drinks, consisting of 
complex mixtures of oligosaccharides at a sufficient level to induce the shift into a 
metabolic fed state following fasting, whilst also ensuring rapid transit through the 
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stomach and thus meeting the requirements of the AAGBI.  Research then extended to 
examine the effects of preoperative carbohydrate loading, and its associated decrease 
in insulin resistance, on various clinical outcomes.  
 
 
1.1 Effects of preoperative carbohydrate loading 
 
 
1.1.1 Length of stay 
 
Insulin resistance has been shown to be an independent predictive factor for length of 
hospital stay post-surgery (Thorell, Nygren and Ljungqvist, 1999).  Therefore it may be 
expected that through reducing insulin resistance preoperative carbohydrate loading 
could reduce length of stay, but there are currently few studies which have examined 
this.   
 
One study showed a significant reduction of 5.5 days in the median time to fitness for 
surgical discharge for those patients given a carbohydrate drink preoperatively 
compared with those given water (Noblett et al., 2006).  A limitation to the study was 
the impossibility to blind the subjects to the intervention.  Additionally the report does 
not state who randomised the participants, prepared the drinks or took the 
measurements.  Whilst it states that the medical staff were blinded, it does not declare 
whether the nursing staff and chief researchers were blinded and thus there is potential 
for bias.   
 
The reduction in length of stay reported by Noblett et al., (2006) was also reflected by 
Ljungqvist, Nygren and Thorell (1998) who performed a meta-analysis of three 
prospective controlled trials and showed that the use of carbohydrate drinks can 
reduce hospital stay by an average of one day (20%) when compared to overnight 
fasting.   One further report on a double-blind randomised, placebo-controlled study of 
65 participants showed an overall trend towards a reduction in hospital stay in those 
participants who received a carbohydrate drink, but the results were not found to be 
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significant (Yuill, Richardson, Davidson, Garden and Parks, 2005).   Whilst the study 
design appeared to be appropriate to the aims, it was noted that the report did not 
provide a sample size calculation.  
 
Clearly the results appear promising but more research would be valuable due to the 
implications of a reduced stay on both patient wellbeing and healthcare costs. 
 
1.1.2    Preservation of lean body mass  
As discussed above the metabolic response to stress results in catabolism, however, 
with carbohydrate drinks improving glucose uptake post surgery and preventing the 
metabolic fasted state then this may have an effect on lean body mass.  Yuill et al., 
(2005) found in a study of sixty-five surgical patients that even though there was no 
difference in body mass index (BMI) or fat mass between the control and intervention 
groups, a significant reduction in mid-arm muscle circumference was seen in the 
control group, suggesting that the carbohydrate drink was effective at preserving lean 
muscle mass.   
 
Other studies investigated the effects on muscle function, with Noblett et al., (2006) 
demonstrating a significant decrease (11%) in the grip strength of those patients who 
underwent overnight fasting, whilst no significant decrease was shown in those patients 
given carbohydrate drinks.  This suggests that preoperative fasting may be associated 
with a greater degree of protein loss. 
 
Quadricep strength has also been investigated with comparable results to Noblett et 
al., (2006), showing a significantly greater decrease in muscle function when fasted 
compared with carbohydrate loading (Henriksen et al., 2003).   
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1.1.3 Well-being 
 
Well-being can incorporate a number of parameters and was considered one of the 
principal reasons for amending the guidelines on the preparation of patients for 
surgery, in order to reduce discomfort due principally to thirst.  It is therefore interesting 
to consider whether the provision of carbohydrate improves this wellbeing further.     
 
Hausel et al., (2001) concluded from an extensive study of 252 patients that 
preoperative carbohydrate provision increases wellbeing prior to surgery.  Their results 
showed a significant decrease in hunger and thirst in those given carbohydrate drinks, 
and furthermore, the carbohydrate-treated group also showed a significant decrease in 
anxiety, less malaise and less unfitness.  Previous research had also shown a 
reduction in thirst following administration of a carbohydrate drink (Nygren et al., 1995), 
however they did not see any significant change in hunger, or anxiety. It could be 
argued however that comparison is made difficult by the fact the Nygren et al., (1995) 
included only 12 participants in their study.  In contrast to these results, Bisgaard, 
Kristiansen, Hjortso, Jacobsen, Rosenberg & Kehlet (2004) examined general 
wellbeing, fatigue and appetite in a sample of 94 patients and found no differences 
between groups either pre- or post- operatively.   These three studies all used visual 
analogue scores (VAS) to measure well-being parameters. 
 
A further aspect of wellbeing that has been researched is the prevalence of nausea 
and vomiting.  Bisgaard et al. (2004) also examined this parameter post-operatively 
and found no significant improvement in nausea and vomiting in those subjects who 
had received carbohydrate treatment.  However, Hausel, Nygren, Thorell, Lagerkranser 
and Ljungqvist (2005) showed in a randomised control trial of 172 subjects that the 
incidence of postoperative nausea and vomiting was significantly reduced when 
participants were given a carbohydrate drink prior to their surgery, compared to those 
who had fasted or received a placebo. The authors considered that potential 
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confounding factors, including anaesthetic, opioid, antiemetic and intravenous fluid use 
were similar across the groups. 
 
Comparable results have been found more recently, with an observed trend towards a 
reduction in postoperative vomiting in those given carbohydrate treatment, however, 
these results were not found to be significantly different (Faria et al., 2009).  This could 
perhaps in part be due to the small sample size of 21 subjects; nevertheless this 
sample was based on a sample size calculation.  Additionally, although the study was a 
randomised control trial it was not blinded and thus there is the potential for subject and 
observer bias. However, the design of this study made blinding impossible and it may 
have improved the validation of the results if a placebo was used in place of fasting for 
the control.  A further drawback of the study design was that we cannot conclude 
whether the effect seen was due to the actual carbohydrate drink, or just the fact that 
the patient was not fasted, as we know that this independently improves wellbeing.  It is 
possible that the same effect could have been achieved simply through normal clear 
fluids.   
 
It is interesting that Bisgaard et al., (2004) in their double blinded randomized placebo-
controlled trial reported no overall improvement in clinical outcome following 
preoperative carbohydrate loading despite including more subjects than was required 
from the power calculation. They considered that their findings may have been due to 
using subjects who had undergone laparoscopic cholecystectomy, which they felt may 
have been less likely to induce insulin sensitivity due to its minimal invasiveness 
compared to other surgeries.  However, both Hausel et al., (2005) and Faria et al., 
(2009) also studied patients undergoing laparoscopic cholecystectomy and found 
significant improvements in clinical outcome measures in those patients treated with 
the preoperative carbohydrate drink.  Bisgaard et al., (2004) report in their paper that 
participants were contacted by telephone the evening prior to their surgery, which could 
imply that they were not admitted to hospital until the following morning.  The report 
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therefore relies on accurate reporting from the participants on the timings and volume 
of the drinks consumed, something which could affect the reliability of the results. 
Furthermore, the study considered sleep quality and again found no significant 
differences between groups, but it is possible this could be due to the way the data was 
collected. The authors requested the participants keep a record of the time taken to go 
to sleep and to wake up, and also the number of nocturnal episodes of waking. It could 
be suggested that it would be very difficult for participants to measure the time at which 
they got to sleep as they would likely be unable to view a clock during the process of 
going from wakefulness to sleep, and they may therefore estimate. Furthermore it is 
not clear whether there was a criteria for measuring these parameters, for example 
whether nocturnal waking constitutes solely waking to turn over or being awake for a 
specified length of time. 
 
1.1.4 Nutritional intake 
 
Only one study was found that measured postoperative nutritional intake (Henriksen et 
al., 2003) and this requested participants to keep their own records of diet and fluids 
consumed during their admission. It was found that preoperative carbohydrate loading 
did not affect postoperative nutritional intake.  Whilst it could be argued that self-
reporting of intake may reduce accuracy, it could be considered that a third party 
completing diet and fluid record charts would be unlikely to increase accuracy as it 
would rely on to constant monitoring of the patients, something that is not possible on 
general wards in most hospitals. 
 
On a similar matter, Hausel et al., (2001), examined preoperative discomfort using a 
visual-analogue scale and found that preoperative hunger and thirst were significantly 
reduced when carbohydrate drinks were administered, compared with water alone, 
thus improving general patient wellbeing.    
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1.1.5 Postoperative complications 
 
It has been proposed that the reduction in insulin resistance may have an effect on 
postoperative complications; however there is currently very little research in this area. 
Noblett et al., (2006) found the incidence of postoperative complications to be the same 
in the carbohydrate group as the fasting group.  One other study has examined the 
effect of preoperative nutrition on immunity and found that when subjects were given 
pre-operative nutrition then exposed to a variety of different intradermal antigens 
postoperatively, the cellular immunity response increased (Rasmussen, Segel, Trier 
Aagaard and Hessov, 1985). This study however was carried out prior to the 
development of carbohydrate drinks and thus used parenteral nutrition for one week 
prior to surgery.  Furthermore, the subjects all received the same treatment, and 
therefore the lack of a control group suggests that it may not be possible to extrapolate 
these findings to conclude about preoperative carbohydrate drinks, however they do 
provide optimism for further research in this area.  
 
1.2 Cancer 
 
The population being studied in this trial is those undergoing elective surgery for 
colorectal cancer.  Cancer is a major concern in the United Kingdom, and is currently 
the leading cause of mortality for individuals under the age of 75 years (Department of 
Health, 2007).  Currently health costs for cancer in England are approximately £4.35 
billion each year (Department of Health, 2007).  The most recent information released 
by the Office for National Statistics reports that colorectal cancer is the second most 
common cancer for women and third most common for men within the United Kingdom 
(Office for National Statistics, 2010) and therefore this type of cancer is clearly having a 
significant effect on the population and economy of this country.  Disturbingly, a recent 
study predicted that the incidence of colorectal cancer is likely to rise in view of the 
increasing obesity epidemic (de Vries et al, 2010).  Moreover, cancer incidence in 
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general is predicted to increase due to the effect of population growth and increasing 
lifespan (Department of Health, 2007).   
 
Of the total expenditure on cancer programmes, approximately 27% is being spent on 
inpatient costs (Department of Health, 2007).  Therefore, methods to improve recovery 
and reduce hospital stay are likely to reduce costs to the National Health Service 
(NHS) and also have a considerable impact on the patient. As well as the psychological 
impact of recovering more rapidly there are other factors, for example reduced loss of 
earnings, that will benefit the patient.  This is also particularly relevant in the current 
climate where the NHS is required to save £15-20 billion by the end of 2013/14 
(Department of Health, 2009). 
 
Colo-rectal cancer is classified according to pathological staging and in turn this 
determines the treatment and likely prognosis of patients.  The predominant factor in 
staging is the extent to which surrounding tissues has been invaded by the tumour.  
There are two staging systems used in the UK, these are outlined in figure 3. 
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Figure 3. Staging of colorectal cancer (Taken from Treanor and Quirke, 2007)
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1.3 Aims and objectives 
 
From the literature review it can be seen that the recent change in preoperative fasting 
guidelines has resulted in a new area of dietetics being developed in the form of 
preoperative carbohydrate loading, with extensive research suggesting that there are 
significant benefits to be achieved.  So much so that the recent ESPEN guidelines 
(Braga et al., 2009) recommend preoperative carbohydrate loading to be the primary 
treatment for most patients, based on grade A evidence.  It could be argued however, 
that whilst the greater part of the evidence is based on randomised controlled trials, 
there have been many that are not blinded and also very few meta-analyses or 
systematic reviews in order to analyse combined findings and draw overall conclusions.  
It is also notable that most of the research to date is from other European countries, 
and thus it is possible that these populations are not representative of those being 
treated at Salford Royal NHS Foundation Trust.  For example, socio-economic status 
and ethnic composition may vary, which both in turn affect dietary choices and 
underlying nutritional status prior to surgery.   
 
Of primary importance, however, is that almost all research to date has examined only 
the immediate/early postoperative metabolic and physiological effects and there has 
been only one study investigating long-term outcomes.  It should be considered 
whether by using carbohydrate loading we could be discharging patients quicker, but 
then delaying the identification of potential nutritional problems.  Following discharge it 
may be harder to identify these problems and the appropriate support may be less 
accessible from the home.  The aim of this study is to specifically test the hypothesis 
that preoperative carbohydrate loading results in longer term improvements in 
wellbeing, sustained return of postoperative physical function and better retention of 
muscle mass and nutritional status at a later (and potentially more clinically relevant 
and useful) stage in the postoperative recovery period. (See table 1). 
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 Outcomes Objectives Hypotheses 
Main aim To investigate the long-term effects of preoperative carbohydrate 
loading on colorectal patients  
Primary Weight and 
anthropometry  as a 
measure of nutritional 
status 
To investigate whether 
carbohydrate loading 
affects changes in 
weight and 
anthropometry from 
pre-op to 30 days post 
surgery 
Carbohydrate loading 
results in better 
retention of weight 
and muscle mass at 
30 days post surgery. 
Secondary Nutritional intake as a 
measure of nutritional 
status. 
To investigate whether 
carbohydrate loading 
affects the time taken 
to meet nutritional 
requirements. 
 
Carbohydrate loading 
improves nutritional 
intake and status 
immediately post-
surgery and at 30 
days post surgery. 
Other 
outcomes 
Relationship between 
carbohydrate loading 
and wellbeing. 
 
 
 
 
 
Time spent on a high 
dependency unit 
(HDU) and overall 
length of stay in 
hospital. 
 
 
Activity levels as a 
measure of physical 
function  
 
To investigate whether 
carbohydrate loading 
affects changes in 
wellbeing and pain 
scores from pre-op to 
30 days post surgery.  
 
 
To investigate whether 
carbohydrate loading 
affects the number of 
days spent on HDU 
and length of stay. 
 
 
To investigate whether 
carbohydrate loading 
affects physical activity 
levels. 
Carbohydrate loading 
results in short and 
longer term 
improvements in 
wellbeing. 
 
 
 
Carbohydrate loading 
reduces length of time 
spent on HDU and 
overall length of stay.  
 
 
 
Carbohydrate loading 
results in improved 
return of physical 
function post surgery. 
 
Table 1.  Study aims and objectives. 
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2.  Methods 
 
 
2.1 Design 
 
This double-blinded placebo controlled randomised control trial took place at Salford 
Royal NHS Foundation Trust (SRFT).  All data was gathered by one trained research 
dietitian to prevent inter-observer bias.   
 
A sample size calculation was used (appendix 1), concluding that in order to see 
differences at 0.05 level of significance 90 recruits were required in each group.  It was 
decided that the scale of the study was much greater than was feasible with one 
researcher in the space of the time allocated, and thus the decision was made to carry 
out this study as a pilot trial, with a view to extending it in the future.  The intention was 
to include 10 participants in each group however due to poor uptake and recruitment, 
this was reduced to seven participants in each group in order that the trial could be 
completed within the time allocation. 
 
Ethical approval was granted by Salford and Trafford Local Research Ethics 
Committee, and the Research and Development department at Salford Royal NHS 
Foundation Trust (SRFT) (Appendix 2). 
 
2.1.1  Population and subjects 
 
All colorectal cancer participants over the age of 18 years of age listed for potentially 
curative colorectal cancer surgery at SRFT were invited to participate in this double-
blinded placebo controlled randomised control trial. Initially the trial included only 
participants undergoing open abdominal surgery, however after only six patients were 
recruited in the first eight months, an amendment to the protocol was submitted to the 
ethics committee to extend eligibility to laparoscopic surgery.  This was accepted and 
thus the inclusion criteria then comprised of both open abdominal surgery and 
laparoscopic abdominal surgery.  In order to prevent the research dietitian influencing 
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invitees, the colorectal nurses or Enhanced Recovery After Surgery (ERAS) Specialist 
Nurse provided the invitation letter and participant information sheet to participants 
meeting the inclusion criteria, at the time of their consultant appointment.  The 
participants then completed the tear-off slip and returned this to the research dietitian in 
order that they could be contacted for their consent and initial assessment.  There were 
no instances of any participants who did not speak English as their first language; 
however interpretations would have been used if this was the case.  Subjects received 
no reimbursement for their participation in the trial. 
 
A criteria was devised for participants to be excluded from participation which consisted 
of those who were unable to give written informed consent and participants with the 
following conditions: neurological impairment or dementia, pre-existing conditions 
limiting mobility and independence at home (e.g. severe rheumatoid arthritis), 
advanced cancer undergoing palliative surgery (likely to have a progressive decline in 
physical status irrespective of treatment), Diabetes Mellitus, a history of gastric surgery 
or any other clinical conditions known to impair gastric emptying. 
 
A dietitian who was not participating in the study randomised each patient at point of 
entry, following patient consent, to avoid selection bias. Patients were stratified into two 
groups: treatment group or control group using simple randomisation. An envelope was 
used containing the names of both groups and the dietitian stratifying the patients 
blindly removed one name to determine which group that patient went into. Neither the 
research dietitian, nor the surgical or nursing teams were aware of the allocation; this 
was kept in a locked filing cabinet in the dietetic department until the data analysis 
step.  The patients were not aware of which group they were allocated to, and the 
drinks were matched to taste.  
 
The carbohydrate drink used in this study was ‘Preload’©, a product of Vitaflo Ltd.  
Preload was created specifically for the purpose of carbohydrate-loading prior to 
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surgery and is available in 50g sachets, containing 190kcal and 40g carbohydrate.  
Each 50g sachet is mixed with 400ml cold water to produce an odourless and 
colourless low-osmolality (120mOsm/kg) drink, (see appendix 3 for nutritional analysis).  
 
The placebo drink was derived using 400ml cold water and 7.5tsp granular sweetener, 
to produce an odourless and colourless drink providing a total of 14.2kcal in 400ml.  
These measurements were deemed by the research dietitian, and two dietitians who 
were not participating in the study, to be a match to the taste of Preload.  
 
2.2    Procedures: Pre-surgery 
 
Once participants had consented to partake they were visited either at home, or in pre-
op outpatient clinic for their initial assessment, a minimum of seven days prior to 
admission.  The following demographical details were recorded: age, date of birth, sex, 
stage and site of cancer.   The interview consisted of the following components: 
(i) Measurement of  
a. weight, height and BMI 
b. mid arm muscle circumference (MAMC).  
c. grip strength 
(ii) Explaining and gaining participant’s consent to wear the SenseWear® 
Armband for three consecutive days. 
(iii) Explaining and gaining participant’s consent for them to complete a detailed 
three day food diary.  
(iv) Calculation of nutritional requirements 
(v) Well-being assessment 
 
Details of the procedures for each of the components are listed below. These results 
were then used as baseline data for each participant and allowed comparison against 
outcome data at 30 days postoperatively.  Therefore each participant acted as their 
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own control for nutritional intake, nutritional status, well-being, energy expenditure and 
activity levels.   
 
2.2.1  Weight, height and BMI 
Participants were weighed using calibrated stand-on Seca® scales, and all subjects 
were asked to remove their shoes and wear light clothing.  Height was measured using 
a wall mounted tape measure or a Seca® portable stadiometer.  It was necessary to 
use two different methods for height measurement as the assessments were carried 
out in either the home or hospital setting.  The two devices were tested for 
comparability prior to commencing the study.  The weight and height measurements 
enabled calculation of BMI, using the following equation (Garrow and Webster, 1985): 
  
Weight in kilograms (kg) 
(Height in metres)2 
 
 
2.2.2  Mid arm muscle circumference 
 
Lean body muscle mass was estimated by measuring mid-upper arm circumference 
(MUAC) (Bishop, Bowen and Ritchley, 1981).  Subcutaneous fat stores were then 
estimated by measuring tricep skinfold (TSF) measurements, using Holtain skinfold 
calipers at the same midpoint of the triceps. In order to achieve reliable results each 
measurement was taken three times and an average value used.  The validity of these 
measurements is optimised as the same research dietitian performed each 
measurement for every subject, using the same equipment (Gibson, 2005). 
 
Mid Arm Muscle Circumference (MAMC), which is an index of muscle mass, was then 
calculated using the following equation (Bishop et al, 1981): 
 
MAMC(cm)  =  MAC(cm)– (TSF(mm) x 0.314).  
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2.2.3  Grip strength 
 
Grip strength was measured using a Takei single spring handgrip dynamometer.  The 
device was held by the participant in the non-dominant hand and squeezed three 
times, with the highest reading being recorded.  This result provides an indication of 
muscle strength and thus gives a functional indicator of nutritional status.  Results were 
compared to reference values for age and gender (Goode, Howard and Woods, 1985; 
Klidjian, 1982).  
 
 
2.2.4  Nutritional assessment 
 
Energy requirements were estimated using the equations of Schofield (1985) to 
calculate basal metabolic rate (BMR), which were then adjusted for physical activity 
level (Department of Health, 1991) based on reported activity level.  Stress factors 
were not added preoperatively.  If patients had a BMI of greater than 30 then the 
energy requirement was taken as BMR only, in line with ASPEN recommendations 
(A.S.P.E.N Board of Directors and the Clinical Guidelines Task Force, 2002).  The 
results for energy requirements were then able to be compared with the resting energy 
expenditure measurement obtained from the SenseWear® armband (see section 2.2.6). 
 
Nitrogen requirements were calculated using the normal value of 0.17g/kg/day (Elia, 
1990) and then converted to protein by multiplying by 6.25.   
 
Participants were requested to complete a detailed diary of every food and drink 
consumed for three consecutive days to establish their baseline nutritional intake. This 
was then analysed by the research dietitian using Microdiet (Downlee Systems Ltd, 
Chapel-en-le-Frith), based on the data set of food and nutrients published in McCance 
and Widdowson (2002).  
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2.2.5  Wellbeing and pain assessment 
 
Visual analogue scales were used, based on the validated tool used by Hausel et al., 
(2001) to examine subject’s anxiety, depression, hunger, inability to concentrate, 
malaise, nausea, pain, thirst, tiredness, unfitness and weakness (appendix 4).  
Subjects were asked to mark on the 100mm scale where they perceived themselves to 
be at the moment in time for each parameter.  
  
 
2.2.6  SenseWear® armband 
 
The SenseWear® Armband is a simple, non-invasive device, which allowed 
simultaneous collection of heat loss, body movement and position data to compute 
metabolic data in participants. The armband has four sensors to measure skin 
temperature, galvanic skin response, heat flux sensors and a two axis accelerometer 
(to measure motion). These sensors enabled the calculation of the following data daily: 
• total energy expenditure (TEE),  
• physical activity duration,  
• duration lying down,  
• duration sleeping  
• number of steps taken  
 
The SenseWear® armband was worn on the right upper arm and participants were 
advised to avoid getting the device wet.  A new battery was provided in each device.  
The armband has been validated successfully against the doubly labelled water (DLW) 
technique (Mignault, St. Onge, Karelis, Allison and Rabasa-Lhoret, 2005).  
 
2.2.7  Admission 
The afternoon prior to their surgery, participants were admitted to Salford Royal NHS 
Foundation Trust and seen by the research dietitian. The drink was prepared in a clear 
jug by the dietitian who had randomised the patient, and information regarding the trial, 
contact details for the research dietitian and instructions for administering the drink 
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were given to the nursing team.   Furthermore a copy of the signed consent form was 
placed in the written medical notes and an entry made on the patient’s electronic notes 
to inform all staff of this patient’s involvement in the clinical trial.  The participant was 
provided with a well-being and pain assessment to complete the following morning 
prior to their surgery.  Also at this time, the SenseWear® armband and completed food 
diary were collected from the patient.  
 
Patients were requested to consume their drink at the following times: 
400ml evening prior to surgery 
            400ml before 4am morning prior to surgery 
            400ml 2 hours prior to surgery. 
 
The total volume of drink consumed, out of the 1200ml provided, was recorded by the 
nursing staff on the ward. 
 
   
2.3    Procedures: Post surgery 
 
Participants were monitored daily from day one post surgery by the research dietitian.  
They were asked to wear the SenseWear® Armband continually for 14 days or until fit 
for surgical discharge as defined by the surgical team (whichever came first). 
 
 
2.3.1  Nutritional assessment 
 
Daily food record charts were kept by nursing staff in order that energy and protein 
intake could be assessed and these were later analysed by the research dietitian using 
Microdiet to establish participant’s daily energy and protein intake for days one to three 
post surgery, and their overall energy intake during admission.   
 
 
2.3.2  Wellbeing and pain scores 
 
The wellbeing questionnaire was completed by patients every other day during their 
admission. A pain questionnaire was used, based also on the validated visual analogue 
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score used by Hausel et al (2001) to determine pain experienced when carrying out 
various functions (appendix 5). 
 
During admission the following data were also collected: 
• Length of time the patient spent on HDU area, as defined by surgical team, 
before transfer to the ward.  
• Postoperative complications, as defined by surgical team 
• Physiological and Operative Severity Score for the enUmeration of Mortality 
and Morbidity (POSSUM score) (Copeland, Jones and Walters, 1991)  
• Presence of Stoma  
• Length of time taken for stoma to function or for the patient to open their bowels   
• Total length of hospital stay  
 
2.3.3  POSSUM score 
POSSUM is the abbreviation for Physiological and Operative Severity Score for the 
enUmeration of Mortality and Morbidity.  This is used by the colorectal surgeons at 
SRFT and is calculated using 12 physiological and six operative parameters (appendix 
6).  This enables a prediction of mortality and morbidity.  These scores were calculated 
by each participant’s respective consultant surgeon.  
  
2.3.4  Discharge 
When patients were considered fit for discharge by the surgical team then the 
SenseWear® armband was removed and the following parameters measured, 
comparable to the pre-op assessment: 
(i) Weight, height and BMI. 
(ii) MAMC 
(iii) Grip strength. 
(iv) Calculation of nutritional requirements 
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(v) Well-being assessment 
 
Energy requirements were re-calculated using most recent weights and adding a stress 
factor of 10% in view of recent uncomplicated surgery (Long, Schaffel, Geiger, Schiller 
and Blakemore, 1979).  As with the preoperative assessment, those participants with a 
BMI greater than thirty had energy requirements calculated as BMR (A.S.P.E.N Board 
of Directors and the Clinical Guidelines Task Force, 2002).   
Nitrogen requirements were calculated using the hypermetabolic value of 0.2g/kg/day 
(Elia, 1990) and then converted to protein by multiplying by 6.25.   
 
2.4    Procedures: Post-discharge 
 
Each participant was contacted to arrange a home visit by the research dietitian on day 
30 following their date of surgery, or the closest possible date to this.   
 
Three days prior to this the research dietitian delivered the SenseWear® armband to 
the participant in order that it could be worn for three consecutive days and then 
removed at their final assessment, and a three day food diary was provided for 
completion by the participant.   
 
At the final assessment the following parameters were again measured using the 
methods documented above: 
(i) Weight, height and BMI. 
(ii) MAMC 
(iii) Grip strength. 
(iv) Calculation of nutritional requirements 
(v) Well-being assessment 
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Energy requirements were re-calculated using most recent weights and no stress factor 
was used as it was deemed that patients would be likely to be out of the flow phase of 
the surgical stress response. As with the preoperative assessment, those participants 
with a BMI greater than 30 had energy requirements calculated as BMR (A.S.P.E.N 
Board of Directors and the Clinical Guidelines Task Force, 2002).   
 
Nitrogen requirements were calculated using the normal value of 0.17g/kg/day (Elia, 
1990) and then converted to protein by multiplying by 6.25.   
 
A summary timeline of the trial’s design is shown overleaf.  
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1 week prior to surgery 
Eligible patient given: 
-Participant Invitation 
-Participant information sheet 
-Participant consent form.
Patient consents to participation.
Patient randomly assigned to control or intervention group  
Assessment with Research Dietitian at outpatient clinic or patient’s home: 
- 3 day nutritional assessment  
- Assessed for weight, height, BMI, TSF,MAMC and MUAC. 
- Well-being questionnaire 
- Explain and consent for Sensewear armband  
Patient given 400ml drink: 
Control: flavoured water   Case: Preload 
Patient given 400ml drink: 
Control: flavoured water   Case: Preload 
-Sensewear armband worn continually for 14 days, or until fit for surgical       
discharge. 
- Patients seen daily to record:  
Nutritional intake; well-being and pain score; length of time on HDU; post-op 
complications; POSSUM score; presence of stoma; length of time taken to 
meet nutritional requirements; length of time taken for the stoma to function or 
for patient to open bowels; length of hospital stay. 
 
- Armband removed. 
- Assessed for weight, height, BMI, TSF,MAMC and MUAC. 
- Well-being questionnaire and pain questionnaire 
Patient seen in outpatient clinic or at their home. 
-Sensewear armband attached for three days prior to final assessment. 
- 3 day nutritional assessment  
- Assessed for weight, height, BMI, TSF,MAMC and MUAC. 
-Well-being questionnaire 
Patient completes involvement in trial
Evening prior to surgery 
2 hours prior to surgery 
Before 4am morning of 
surgery 
Daily from day 1 post-
surgery. 
Fit for surgical discharge/ 
14 days post-op 
30 days post-op 
Patient given 400ml drink: 
Control: flavoured water   Case: Preload 
 
Completes well-being questionnaire 
Figure 4. Summary timeline of trial 
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2.5  Data analysis 
 
Data were entered into a Microsoft Excel spreadsheet and subsequently the research 
dietitian was informed of the randomisation code prior to analysis to allow comparison 
between the two groups.  The statistical software package IBM® SPSS® version 17 was 
used for all analysis.   Mean values and standard deviation (SD) or standard error of 
the mean (SEM) were calculated and median values were also used for several data.   
When measuring changes in values between different time intervals, mean values and 
95% confidence intervals of the difference were calculated.   
 
All data was checked for errors prior to carrying out analyses using the IBM® SPSS® 
function of analysing variables.  The Kolmogorov-Smirnov test for normality was used 
in order to determine normality.  It was concluded that parametric tests should be used 
for all data. 
 
Statistical analysis was not carried out for baseline or surgical data due to the small 
amount of data.  Due to observed differences between the control and intervention 
groups at baseline then all anthropometric data were analysed by comparing changes 
within groups between the time intervals of: preoperative assessment to discharge from 
hospital; discharge from hospital to 30 days post-surgery; and preoperative 
assessment to 30 days post-surgery.  Independent sample T-tests were used for these 
analyses.  
 
Data for nutritional intakes were compared between the two groups, by analysing mean 
intakes of energy and protein intakes using independent sample T-tests for different 
time periods throughout the study.   Wellbeing, pain, physical function and resting data 
were assessed in the same way by analysing mean data between groups for each time 
period using independent sample T-tests.  
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Length of time on HDU and length of admission were analysed also using independent 
sample T-tests, however for the statistical analysis of the complications related to 
surgery, Fisher’s exact test was used due to the small number of data.  The level of 
significance was set at 0.05 for all analyses. 
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3.  Results 
 
 
3.1   Baseline and surgical data 
 
Between 1st April 2008 and 31st January 2010, 18 patients consented to partake in the 
clinical trial.  During this time a total of 101 patients underwent surgery for colorectal 
cancer, however not all of these may have been eligible for participation according to 
the trial exclusion criteria.     
 
Of those who consented, one subject who was due for open surgery had this converted 
to laparoscopic surgery; this was prior to the change in inclusion criteria and thus she 
was excluded from the study at that time.  A further two patients were excluded due to 
the Sensewear® armband failing to record any pre-operative results, thereby leaving a 
large gap in the data collected.    Following the amendment of inclusion criteria to 
include laparoscopic patients, only one laparoscopic patient consented and completed 
the trial therefore it was considered that due to insufficient numbers in this group it was 
necessary to also exclude this patient.  This is due to differing stress responses 
between laparoscopic and open surgery (COLOR, 2005) making it likely that this 
patient was not matched to the rest of the population within the group.  It is known that 
laparoscopic surgery is less invasive and traumatic, resulting in a reduced catabolic 
effect and immunological response (COLOR, 2005).  Furthermore, a previous study 
has shown insulin resistance to be reduced in laparoscopic compared with open 
surgery (Thorell et al., 1996).  The remaining 14 subjects completed their participation 
in the trial.  
 
The participants consisted of 10 males and 4 females, of median age 65.5yrs (range 
44-83yrs), see table 2 for all baseline data.  There was no negative feedback from any 
recruits on the palatability of either drink, and the nursing notes showed that all 
subjects consumed the total amount of drink required.  
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 Intervention (n=7) Control (n=7) 
Age (yrs) 
Median (range) 
69 (55-77) 62 (44-83) 
Gender                Male 
                          Female 
6 (86%) 
1 (14%) 
4 (57%) 
3 (43%) 
Mean weight (kg) 85.5 (SD 15.3) 73.3 (SD 15.4) 
Mean BMI (kg/m2) 29.8 (SD 4.7) 25 (SD 4.87) 
Mean MAMC (cm) 27.5 (SD 3.7) 26 (SD 3.4) 
Mean grip strength (mm) 34.1 (SD 9.4) 30.6 (SD 9.7) 
Mean daily energy 
requirement (kcal) 
2549 (SD 444) 2212 (SD 625.7) 
Mean daily energy intake 
(kcal) 
1861 (SD 439.7) 1942 (SD 636.8) 
Mean no. pts meeting >90% 
of energy requirement (%) 
2 (29%) 2 (29%) 
Mean daily protein 
requirement (g) 
81 (SD 6.7) 75 (SD 15.3) 
Mean daily protein intake (g) 79 (SD 14.5) 79 (SD 26.2) 
Mean no. pts meeting >90% 
of protein requirement (%) 
5 (71%) 4 (57%) 
Mean physical activity 
duration (hr:min) 
1:13  
(SD 0:46) 
1:32 
(SD 1:13) 
Mean number of steps 5658 (SD 3875) 7698 (SD 4606) 
Mean hours of sleep (hr:min) 5:45  
(SD 1:58) 
5:51 
(SD 2:56) 
 
Table 2. Descriptive data of all participants at baseline. 
 
 
All participants underwent open surgery for potential curative resection of colorectal 
cancer, data was collected on the site and stage of the cancers, note one patient in the 
control group had two carcinoma, of Dukes B and C (table 3). 
 
Cancer Intervention Control 
Site    
 Rectum 5 6 
 Mid-ascending colon 2  
 Sigmoid loop  1 
 Caecum  1 
Stage    
 Dukes A 4  
 Dukes B 2 5 
 Dukes C 1 3 
 
Table 3. Data for all participants on the cancer site and stage. 
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Only three participants did not have a stoma formed during their surgery and all three 
of these patients were in the intervention group.  The length of time for either the stoma 
to work, or bowels to open was recorded however data was missing for one participant 
in the intervention group, see table 4.    
 
Number of days post surgery Intervention Control 
0  1 
1 3 2 
2  1 
3 1 1 
4 2  
5   
6   
7  1 
8   
9   
10  1 
Total 6 7 
Mean number of days 1.5 2 
 
Table 4. Time taken for stoma to work or bowel to open (data in red for those without a stoma). 
 
 
 
3.2   Outcome data 
 
 
3.2.1 Anthropometry 
 
To analyse the anthropometric data, comparisons were made within the two groups, 
intervention and control, at each of the three time intervals: from preoperative 
assessment to discharge from hospital; from discharge from hospital to 30 days post-
surgery; and from preoperative assessment to 30 days post-surgery.  Values for the 
mean difference within groups at each interval showed no significance for any 
anthropometric parameter.   Indeed in all instances the confidence intervals of the 
difference include zero which indicates no effect of the intervention, as shown in tables 
5 to 8, and figures 5 to 8. 
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 Pre-op to discharge Discharge to 30d post-surgery Pre-op to 30d post-surgery 
 Intervention Control Intervention Control Intervention Control 
Mean weight 
difference (kg) 
-4.79  
(SE 8.22) 
-5.49 
(SE 7.59) 
0.29 
(SE 8.1) 
-0.314 
(SE 7.17) 
-4.5 
(SE 8) 
-5.8 
(SE 7.85) 
95% CI of the 
difference 
-13 to 22.7 -11 to 22 -17 to 17 -15 to 15 -13 to 22 -11 to 22 
P value 0.571 0.484 0.972 0.966 0.587 0.474 
 
Table 5.  Mean weight change (kg) within each group at each of the three time intervals explored. 
 
 
 
 
 Pre-op to discharge Discharge to 30d post-surgery Pre-op to 30d post-surgery 
 Intervention Control Intervention Control Intervention Control 
Mean BMI 
difference (kg/m2) 
-2.01 
(SE 2.42) 
-1.84 
(SE 2.21) 
0.07 
(SE 2.20) 
-0.24 
(SE 2.01) 
-1.94 
(SE 2.30) 
-2.06 
(SE 2.43) 
95% CI of the 
difference 
-3.28 to 7.31 -3.67 to 5.99 -4.87 to 4.72 -3.47 to 5.27 -3.07 to 6.96 -3.24 to 7.35 
P value 0.423 0.611 0.975 0.662 0.415 0.414 
 
Table 6.   Mean BMI change (kg/m2) within each group at each of the three time intervals explored. 
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 Pre-op to discharge Discharge to 30d post-surgery Pre-op to 30d post-surgery 
 Intervention Control Intervention Control Intervention Control 
Mean MAMC 
difference (cm) 
-0.91 
(SE 2) 
-1.45 
(SE 1.68) 
0.21 
(SE 1.95) 
-0.16 
(SE 1.65) 
-0.71 
(SE 1.93) 
-1.61 
(SE 1.79) 
95% CI of the 
difference 
-3.44 to 5.28 -2.19 to 5.11 -4.47 to 4.05 -3.45 to 3.77 -3.49 to 4.91 -2.3 to 5.52 
P value 0.914 0.401 0.917 0.925 0.720 0.386 
 
Table 7.  Mean change in MAMC (cm) within each group at each of the three time intervals explored. 
 
 
 
 
 Pre-op to discharge Discharge to 30d post-surgery Pre-op to 30d post-surgery 
 Intervention Control Intervention Control Intervention Control 
Mean grip strength 
difference (mm) 
-3.43 
(SE 5.21) 
-2.96 
(SE 4.91) 
0.86 
(SE 5.30) 
-0.96 
(SE 4.51) 
-2.57 
(SE 5.11) 
-3.93 
(SE 4.81) 
95% CI of the 
difference 
-7.93 to 14.79 -7.73 to 13.65 -12.41 to 10.7 -8.9 to 10.8 -8.6 to 13.71 -6.55 to 14.4 
P value 0.523 0.557 0.874 0.834 0.624 0.430 
 
Table 8.  Mean change in grip strength (mm) within each group at each of the three time intervals explored. 
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Figure 5.  Changes in weight (kg) for each subject at the three time points. 
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Figure 6.  Changes in BMI (kg/m2) for each subject at the three time points. 
 
 
 
 
 
 
47 
 
0
5
10
15
20
25
30
35
Intervention
pre-op
Intervention
d/c
Intervention
30d post d/c
Control pre-
op
Control d/c Control 30d
post d/c Time
M
A
M
C
 (c
m
)
 
 
Figure 7.  Changes in mid arm muscle circumference (MAMC) for each subject at the three time 
points. 
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Figure 8.  Changes in grip strength (mm) for each subject at the three time points. 
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3.2.2  Nutritional intake 
Mean energy and protein intakes were compared between the intervention and 
control groups for days one to three post surgery.  It was seen that energy and 
protein intakes were higher in the intervention groups than controls (tables 9 and 
10).  Despite this, comparison of mean intakes for the overall duration of admission 
showed the energy and protein levels to be higher in the control group (tables 11 
and 12), although differences did not reach significance.  Furthermore, there was 
no significant difference in the percentage of patients who met more than 90% of 
their requirements at any time point (tables 13 and 14, figure 9), and indeed very 
few patients were able to achieve this intake.  In all instances the confidence 
intervals of the difference include zero which indicates no effect of the intervention.
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 Day 1 post surgery Day 2 post surgery Day 3 post surgery 
Intervention Control Intervention Control Intervention Control 
Mean energy 
intake (kcal) 
551 
(SD 683.1) 
422 
(SD 490.6) 
769 
(SD 465.4) 
484 
(SD 461) 
911 
(SD 507.7) 
652 
(SD 553.3) 
95% CI of the 
difference 
between groups 
-563.4 to 821.8 -282.1 to 852.7 -388.8 to 906.4 
P value 0.692 0.292 0.398 
 
Table 9.  Mean energy intake (kcal) for each of the control and intervention groups at days one, two and three post surgery. 
 
 
 
 
 Day 1 post surgery Day 2 post surgery Day 3 post surgery 
Intervention Control Intervention Control Intervention Control 
Mean protein 
intake (g) 
26 
(SD 33.2) 
16.8 
(SD 19.4) 
29 
(SD 16.8) 
23 
(SD 22.2) 
38 
(SD 24.2) 
23 
(SD 18.9) 
95% CI of the 
difference 
between groups 
-22.5 to 40.8 -18 to 29.6 -11.6 to 42.2 
P value 0.541 0.602 0.237 
 
Table 10.  Mean protein intake (g) for each of the control and intervention groups at days one, two and three post surgery. 
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 During admission in hospital 30 days post-surgery 
Intervention Control Intervention Control 
Mean energy intake (kcal) 712 
(SD 268.2 ) 
867 
(SD 282.4) 
1880 
(SD 482.9) 
1845 
(SD 839.8) 
95% CI of the difference between groups -475.8 to 165.7 -783.8 to 854.9 
P value 0.313 0.926 
 
Table 11.  Mean energy intake (kcal) for each of the control and intervention groups.  
 
 
 
 
 During admission in hospital 30 days post-surgery 
Intervention Control Intervention Control 
Mean protein intake (g) 31 
(SD 10.6) 
45 
(SD 16) 
79 
(SD 16.4) 
81 
(SD 35.5) 
95% CI of the difference between groups -30.5 to 3.28 -35.1 to 30.6 
P value 0.104 0.883 
 
Table 12.  Mean protein intake (g) for each of the control and intervention groups. 
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 Day 1 post surgery Day 2 post surgery Day 3 post surgery 
Intervention Control Intervention Control Intervention Control 
Number meeting >90% of energy 
requirements 
2 (28.6%) 2 (28.6%) 0 (0%) 0 (0%) 2 (28.6%) 2 (28.6%) 
P value (comparison between 
groups) 
1.0 1.0 1.0 
 
Table 13.  Number of subjects meeting more than 90% of their energy requirements. 
 
 
 
 
 
 Day 1 post surgery Day 2 post surgery Day 3 post surgery 
Intervention Control Intervention Control Intervention Control 
Number meeting >90% of protein 
requirements 
6 (85.7%) 5 (83.3%) 0 (0%) 1 (14.3%) 5 (71.4%) 5 (71.4%) 
P value (comparison between 
groups) 
1.0 1.0 1.0 
 
Table 14. Number of subjects meeting more than 90% of their protein requirements. 
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Figure 9.  Number of subjects meeting more than 90% of their energy and protein requirements. 
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3.2.3 Wellbeing and pain score 
 
The scores for each wellbeing parameter (anxiety, depression, hunger, inability to 
concentrate, malaise, nausea, pain, thirst, tiredness, unfitness and weakness) were 
totalled and an average calculated for each patient at each time interval 
(preoperative assessment, during admission from hospital and 30 days post-
surgery).  Due to the format of the visual analogue scale used to gather these data, a 
higher score indicates reduced wellbeing.  Results showed that mean wellbeing 
scores were higher in the control groups at each time interval (table 15) and 
therefore patients were more anxious, depressed, hungry and so on, although these 
results were not statistically significant.  
 
The pain scores were assessed in the same way, and for these data a higher score 
indicated increased pain.  Pain was not assessed pre-operatively, as outlined in the 
methods as the surgical intervention had not taken place.   Mean pain scores were 
higher in the control group, with a significant difference seen at 30 days post surgery 
(p=0.017) (table 16).  
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 Preoperative assessment During admission 30 days post-surgery 
Intervention Control Intervention Control Intervention Control 
Mean wellbeing score 
(SD) 
18.68  
(SD 14.39) 
28.77  
(SD 21.34) 
30.89 
(SD 11.68) 
47.44 
(SD 6.30) 
16.14 
(SD 7.39) 
39.11 
(SD 20.34) 
95% CI of the difference 
between groups 
-31.29 to 11.11 -33.32 to 0.21 -40.5 to -4.88 
P value 0.320 0.53 0.17 
 
Table 15.  Mean values for wellbeing score of each of the control and intervention groups. 
 
 
 
 During admission 30 days post-surgery 
Intervention Control Intervention Control 
Mean pain score (SD) 28.16  
(SD 17.12) 
33.17 
(SD 18.6) 
16.41 
(SD 7.39) 
39.11 
(SD 20.34) 
95% CI of the difference between groups -25.85 to 15.82 -40.52 to -4.88 
P value 0.610 0.017 
 
Table 16.  Mean values for pain score of each of the control and intervention groups.
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3.2.4  Physical function 
 
Three parameters were used to investigate physical function: physical activity 
duration, number of steps taken and total energy expenditure (TEE).  Each of 
these parameters were measured at the same three time points as the 
anthropometry and nutritional assessment.  Comparisons were made between 
the intervention and control groups, as shown in tables 17-19.   
 
Although the figures varied between the control and intervention groups, there 
were no significant differences between groups over the course of the study.   
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 Preoperative assessment During admission 30 days post-surgery 
Intervention Control Intervention Control Intervention Control 
Mean physical activity 
duration (hr:min) 
1:13 
(SD 0:46) 
1:32 
(SD 1:13) 
0:06 
(SD 0:05) 
0:10 
(SD 0:11) 
0:46 
(SD 0:30) 
0:35 
(SD 0:33) 
95% CI of the difference 
between groups 
-1:30 to 0:51 -0:13 to 0:06 -0:30 to 0:52 
P value 0.561 0.421 0.56 
 
 
Table 17.  Mean values for physical activity (hr:min). 
 
 
 Preoperative assessment During admission 30 days post-surgery 
Intervention Control Intervention Control Intervention Control 
Mean number of steps 
 
5658 
(SD 3875) 
7698 
(SD 4607) 
575 
(SD 402) 
390 
(SD 188) 
4079 
(SD 4295) 
3059 
(SD 2131) 
95% CI of the 
difference between 
groups 
-6998 to 2917 -181 to 551 -3341 to 5381 
P value 0.387 0.292 0.614 
 
 
Table 18.  Mean values for the number of steps taken. 
 
 Preoperative assessment During admission 30 days post-surgery 
Intervention Control Intervention Control Intervention Control 
Mean TEE 
(kcal) 
 
2286.9 
(SD 591.7) 
2303.6 
(SD 692.4) 
1763.1 
(SD 213.1) 
1613.1 
(SD  276.9) 
2026.4 
(SD 472.9) 
1851.7 
(SD 506.7) 
95% CI of the difference 
between groups 
-766.8 to 733.3 -137.8 to 437.8 -455.7 to 805.2 
P value 0.962 0.278 0.551 
 
 
Table 19.  Mean values for the total energy expenditure (TEE) (kcal). 
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3.2.5  Resting data 
Comparisons were made between groups for sleep duration and hours spent lying 
down using independent sample T-tests, as shown in tables 20 and 21.  These 
analyses showed no significant differences however the direction of the data goes 
towards longer sleep duration in the control group at each time period.   
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 Preoperative assessment During admission 30 days post-surgery 
Intervention Control Intervention Control Intervention Control 
Mean hours of sleep 
(hrs:mins) 
 
5:45 
(SD 1:58) 
5:51 
(SD 2:56) 
3:31 
(SD 1:21) 
4:08 
(SD 2:05) 
6:42 
(SD 1:23) 
7:27 
(SD 0:45) 
95% CI of the difference -3:00 to 2:49 -2:40 to 1:25 -2:20 to 0:49 
P value 0.944 0.519 0.302 
 
Table 20.  Mean values for the hours of sleep taken. 
 
 
 Preoperative assessment During admission 30 days post-surgery 
Intervention Control Intervention Control Intervention Control 
Mean hours spent lying down 
(hrs:mins) 
 
7:31 
(SD 2:01) 
7:10 
(SD 3:50) 
5:55 
(SD 3:18) 
5:26 
(SD 3:07) 
8:28 
(SD 1:24) 
9:42 
(SD 1:00) 
95% CI of the difference -3:13 to 3:54 -3:15 to 4:14 -2:55 to 0:27 
P value 0.837 0.781 0.133 
 
Table 21.  Mean values for the number of hours spent lying down.
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3.3  Process outcomes 
 
 
3.3.1  Length of time on HDU and length of admission 
All participants were admitted to the Intensive Care Unit or Surgical High 
Dependency Unit (HDU) following their surgery.  No significant differences were 
seen between groups for length of time on HDU or total length of admission (table 
22).  
 
 Intervention 
 
Control 95% CI of the 
difference 
P value 
Length of 
time on 
HDU 
(days) 
 
4 
(SD 3.2) 
 
5 
(SD 1.7) 
 
-4.1 to 1.8 
 
0.419 
Length of 
admission 
(days) 
 
9 
(SD 4.74) 
 
 
13 
(SD 7.5) 
 
-11.8 to 2.9 
 
0.212 
 
Table 22.  Mean values for length of time spent on HDU, and length of admission.  
 
3.3.2  Complications 
Complications related to the surgery were experienced by three intervention 
participants and four control participants, as shown in table 23.  The most common 
complication overall was postoperative nausea and vomiting however there was no 
significant difference in complications experienced between groups.  
 
Complication Intervention Control P value 
(comparison 
between groups) 
Nausea and 
vomiting 
2 (29%) 3 (42.9%)  
 
 
 
 
1.0 
Ileus 1 (14.3%) 2 (29%) 
Thrombus 0 1 (14.3%) 
Infection 0 1 (14.3%) 
Any of the above 3 (42.9%) 4 (57.1%) 
 
Table 23.  Complications experienced by participants. 
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3.3.3  POSSUM scores 
POSSUM scores for morbitity and mortality were calculated for each patient by their 
respective consultant surgeon, as shown in table 24.   It can be seen that the scores 
were higher in the control group than the intervention group.  No statistical analysis 
was carried out as this was additional data collected for surgical purposes. 
 
Group 
Patient 
no 
POSSUM 
morbitity 
POSSUM 
mortality 
 Intervention 
  
  
1 26.115 1.086
2 13.5 0.6
3 35.4 1.3
4 43 1.9
5 38.7 2.3
6 40.854 2.085
7 42.311 2.028
 Median 38.7 1.9
 Control 1 36.355 1.791
2 45.5 2.4
3 39.2 1.5
4 23.148 0.918
5 76 6
6 62.5 3.2
7 54.983 3.279
 Median 45.5 2.4
 
Table 24.  POSSUM scores for morbidity and mortality for each participant.
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 4. Discussion 
 
 
This pilot study has investigated the role of preoperative carbohydrate loading in 
improving recovery after colorectal surgery, focusing particularly on the long-term effects, 
an area for which there is currently limited evidence. 
 
The trial showed that the direction of the data was towards a reduction in length of 
hospital stay, although this did not reach significance possibly due to a small sample size.   
Further results in this study suggest that carbohydrate loading may have long-term 
benefits including better retention of weight and muscle mass, improved nutritional intake, 
improved wellbeing and improved return of physical function at 30 days post surgery.  
Furthermore the results may back up research on the benefits immediately post surgery, 
including preservation of lean body mass, improved well-being and reduced postoperative 
complications.  Whilst none of these results showed significant differences, this pilot study 
could be used as the basis for a larger randomised control trial.     
 
4.1  Baseline data 
 
Participants were allocated randomly to either the control or intervention groups but due to 
the small number of recruits, the two groups were not matched exactly for gender.  Indeed 
the study overall included more than double the number of males than females and whilst 
it is known that colorectal cancer affects more men than women, this is not exactly 
representative of national incidence.  In 2007 diagnosis rates were reported as 17,100 
male cases and 14,400 female cases (Office for National Statistics, 2010).   The age 
range for both groups also varied, with a range of almost 40 years in the control group, 
and only approximately 20 years in the intervention.  Despite this though, the median age 
was similar for each group, and again representative of national statistics, which show that 
of those people diagnosed with colorectal cancer, greater than four out of five will be over 
the age of 60 years (Office for National Statistics, 2010).    
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The mean weight at baseline differed by 12.2kg between the groups with the mean BMI 
for the control group within normal weight range, however subjects within the intervention 
group were on average overweight.  It could be argued that as the data analysis 
considered mean weight change within each group and not between groups then this may 
not have affected the results.  The mean anthropometry data for each group showed that 
these participants were on average not depleted.  Whilst these data were taken as their 
baseline, it may not be representative of the recruits’ ‘normal’ status and the following 
factors may have influenced this:  
 
 
4.1.1  Altered metabolism. 
 
When participants were recruited to the study they may have been suffering with cancer 
for a period of time, and therefore the baseline weight which was recorded may not have 
been reflective of their ‘normal’ weight.  The study did not examine whether participants 
had already lost weight at their baseline assessment and this would have been valuable to 
know as recent unplanned weight loss has been shown to be an independent risk factor 
for malnutrition (Parekh and Steiger, 2004).  All patients who were entering the study at 
baseline were likely to have had increased energy demands due to their cancer, as 
tumour presence increases resting energy expenditure (Hyltander et al.,1991) and this 
alone could have resulted in weight loss. 
   
4.1.2  Reduced oral intake 
 
The baseline results showed that 1/7 of participants in both the control and intervention 
groups were meeting greater than 90 per cent of their energy requirements whilst the 
number of patients meeting this target for protein was higher in the intervention group, 
though still not optimal.  This compromised intake could have been due to symptoms 
experienced secondary to their cancer, for example abdominal pain (Nygren, 2006) or 
altered bowel habits.  It is also possible that anxiety may have affected dietary intake as 
this is a common emotion associated with a cancer diagnosis; furthermore recruits were 
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assessed at a maximum of one week prior to their surgery and therefore may have been 
apprehensive about their forthcoming treatment and the risks involved.  Anxiety was 
considered as part of the wellbeing assessment at baseline and the results showed that 
patients in the intervention group had a greater feeling of wellbeing than those in the 
control at baseline though this was not significantly different (p=0.320).  Previous research 
by Hausel et al (2001) has only examined the effect of carbohydrate loading on the state 
of wellbeing, and not studied the potential effects that this may have, for example whether 
this may independently affect pain scores or length of hospital stay. 
 
The data for physical activity and number of steps showed the patients to be quite 
sedentary, and again no significant differences were seen between groups.  This again 
could be related to symptoms secondary to their tumour, but also it was noted that a 
number of patients reported at their baseline assessment that they were ‘resting’ prior to 
their surgery and therefore these data may not be representative of their normal status.  
Each group took a similar number of hours sleep per day.   
 
4.2 Preoperative assessment to discharge from hospital 
 
Between baseline preoperative assessment and discharge from hospital the control group 
had a greater decrease in weight and mid-arm muscle circumference than the intervention 
group, which may suggest that the carbohydrate drink helped to preserve lean body mass, 
although there was no significant difference between the two groups.  It is interesting 
however that the results for grip strength showed the control group lost less strength than 
the intervention group, and whilst this was not statistically significant either it did not reflect 
previous studies which had shown less reduction in hand grip strength when subjects 
were given preoperative carbohydrate loading (Noblett et al., 2006 and Henriksen et al., 
1999).  However, these studies examined dominant hand grip strength, whereas this 
study looked at the non-dominant hand as this is normal practice within the UK.    
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The results for physical activity showed that during admission the control group were 
slightly more active.  Interestingly, however the results for the mean number of steps 
taken and the TEE do not reflect this as the mean values for each of these parameters 
were higher in the intervention group.  Comparison of results for physical function 
between the two groups were not significantly different and it is also possible that there 
are some inaccuracies in the recordings.  Therefore further research is required to 
consider the study hypothesis that carbohydrate loading results in improved return of 
physical function post surgery.   
 
Previous research by Yuill et al (2005) suggested that preoperative carbohydrate loading 
preserves lean body mass by increasing glucose supplies.  In combination with a 
decrease in insulin resistance, then the net result is increased glucose uptake and a 
reduced need for other substrates, thereby preserving protein and fat stores.  
 
A further explanation for the preservation of lean body mass could be the direction of data 
towards a higher energy and protein intake in days 1-3 post surgery in the intervention 
group, however this was not statistically significant.  It could be suggested that if more 
energy was being supplied extrinsically then less would be required from intrinsic stores.  
Indeed previous studies have shown that when post-operative nutrition is optimised in 
combination with preoperative carbohydrate loading then nitrogen losses are reduced 
(Soop et al., 2004; Svanfeldt, Thorell, Nygren and Ljungqvist, 2006), However, in the 
present study there were still few subjects in either group meeting more than 90% of their 
energy and protein requirements.  The increased oral intake in the intervention group may 
also be a reflection of the greater feeling of wellbeing seen in this group during their 
admission.  In particular this score included the feeling of nausea, and whilst this wasn’t 
considered independently, it was recorded as a complication and shown to be lower in the 
intervention group, though not statistically significant. Other studies have shown 
conflicting responses, with Hausel et al (2005) finding a significant reduction in nausea 
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and vomiting in patients given preoperative carbohydrate loading, however Bisgaard et al 
(2004) saw no association.   
 
A further factor that may have promoted nutritional intake is the finding that pain scores 
were significantly lower in the intervention group.  The validity of dietary data should be 
considered as daily intake during admission was recorded by nursing or support staff, 
however the records were checked daily with the patient by the researching dietitian.  It is 
possible that participants could have completed the food diaries themselves however this 
could have been considered an added burden for them or also affected validity.  It is well 
known that dietary assessment is open to inaccuracies (Beaton, Burema and Ritenbaugh, 
1997) and these could be either accidental or intentional for example portion sizes may 
have been recorded inaccurately by staff or participants, or foods may have been 
forgotten or purposely omitted.  It is also possible that participants may have been 
unwilling to disclose information on their dietary habits, especially as they knew it was 
being analysed by a dietitian.  Previous research has suggested that subjects may see 
analysis of dietary routines as invasion of their privacy (Blundell, 2000), however these 
participants all consented to the study knowing that dietary data would be collected and 
therefore may be less likely to withheld information.    Furthermore there is a chance that 
inaccuracies could have come about from imprecise interpretation of data when entering 
the data into the analysis software, for example error in portion sizes.  This however is 
likely to be consistent for all participants as it was only the one researcher who carried out 
all the analyses. 
 
Resting data showed variation between groups during admission as the intervention group 
were seen to spend more time lying down however less time asleep.  There are many 
factors that may have affected these parameters, and pain and wellbeing could be 
considered to have a negative impact on sleep, however whilst these scores were lower in 
the intervention group they were not statistically significant.  It is possible that other 
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factors, for example general noise on the ward and interruptions from nursing and medical 
staff may have affected sleep.  Another factor may have been physiotherapy input as this 
may have affected hours spent lying down, and physical activity levels.  Physiotherapy 
from the day of surgery is part of the Enhanced Recovery After Surgery (ERAS) 
programme AT SRFT and therefore all patients should have received this, though the 
intensity would depend on each individual and their ability to mobilise.  Whilst these data 
weren’t collected, this could be considered in future research as a possible factor affecting 
physical function and resting data.   
 
4.3 Discharge from hospital to 30 days post surgery 
 
During this time period perhaps of the most interesting and clinically relevant results were 
seen which would warrant future research.  Weight and therefore BMI were shown to 
increase in the intervention group, and yet decrease further in the control group, though 
due to the small sample size these were not statistically different.  Similarly MAMC and 
grip strength followed the same pattern, however significance levels were not achieved 
again. The data for grip strength is particularly interesting as the results of the intervention 
group were shown to increase following discharge, whereas in the control group they 
decreased.  Whilst none of the grip strength results were statistically significant the 
direction of the data could suggest that the period following discharge is clinically 
important and that the benefits of carbohydrate loading do extend for longer than the days 
immediately post-surgery.  It is known that the catabolic period can extend for up to two to 
four weeks in this patient population (Thorell et al., 1994) however if this catabolic 
response is reduced in those patients receiving preoperative carbohydrate, as previously 
explained, then this may explain why they are not losing intrinsic energy stores.   
 
Whilst it may be expected that dietary intake would also affect weight and lean body 
mass, the results at 30 days post surgery showed similar intakes between the two groups, 
with the intervention group taking on average slightly more energy, yet less protein.  
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Despite this, the number of participants who were meeting more than 90% of their energy 
and protein requirements were exactly the same in both groups.  It is interesting that these 
data showed that only 28.6% of patients in the intervention group were meeting more than 
90% of their energy requirements and yet on average these patients were gaining weight.  
This could reflect inaccuracies in both reported intake using a food diary and also the 
accuracy of the estimated calculated requirements.  The equation used to calculate 
energy requirements was the Schofield equation (Schofield WN 1985) however these 
calculations are based on studies conducted between 1914-1980, of which almost half of 
the subjects were Italian military adults.  It could be argued that this population is not likely 
to be comparable the population being studied in this trial due to the likely differences in 
lifestyle, physical activity levels, diet and the effect these would have on BMR.  As an 
alternative the more recent Oxford equations (Henry 2005) could have been used as 
these include data from a greater number of individuals, from studies up to 2005, and 
exclude outliers and extreme circumstances (for example high altitude data).   
 
 
Another method to collect data on dietary intake could have been used, for example a 
seven day weighed food record.  However this would have been more labour-intensive 
and therefore compliance may have been affected; also this may have affected 
recruitment to the study due to the additional effort required.  It is recommended to use 
independent measures of validity for all methods of dietary assessment (Black et al., 
1993) and in this study it was possible to assess the validity of reported energy intake by 
comparing with energy expenditure.  This was measured using the Sensewear armband, 
a method which itself has been validated against doubly labelled water (Mignault et al., 
2005).  Indeed the mean results for total energy expenditure and energy intake per day at 
30 days post surgery showed a difference of 146.3kcal in the intervention group and 
7.1kcal in the control group, showing that these may actually be accurate representations 
of energy intake. Protein intake was unable to be validated as the usual method would be 
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to use 24-hour nitrogen excretion (Black, Bingham, Johansson and Coward, 1997) 
however there was not the adequate equipment available to use this method in this study.   
 
Wellbeing continued to be greater in the intervention group at 30 days surgery however 
this was not significantly different.  Whilst this seemingly had no effect on energy and 
protein intake, it could be related to physical function and thus their improved 
anthropometry results.  All measures of physical function, (physical activity duration, 
number of steps and TEE) were higher in the intervention group than the control.  It could 
be suggested that if wellbeing parameters were lower, for example weakness, nausea, 
tiredness and malaise then subjects may have felt more able to mobilise; therefore if 
participants are being more active they are more likely to retain muscle mass.  Pain 
scores were significantly lower (p=0.017) at 30 days post surgery and this too may have 
contributed to the difference in physical activity levels.  The confidence interval of this 
difference confirmed that the score in the control group was higher than the intervention 
group and demonstrated that this study was powered enough for the detection of 
differences in VAS scores for pain between groups.  It is significant that participants were 
still in pain at this time following surgery, and this further supports the theory that recovery 
may be improved in those given a preoperative carbohydrate loading.  This may also 
relate to the resting data, according to which the control group spent a longer duration 
lying down each day, and also slept for longer.  
 
 
4.4  Preoperative assessment to 30 days post surgery 
 
Having already examined the effects of preoperative carbohydrate loading at different time 
intervals throughout the study, these results enable us to establish the overall effects seen 
from commencing the study through to the final assessment at 30 days post-surgery.  An 
overall direction in data of reducing weight, MAMC and grip strength was seen, and whilst 
these appeared to be reduced more in the control group, no significant differences were 
seen.  The trend would warrant further research to investigate the hypothesis, as already 
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discussed, that carbohydrate loading results in better retention of weight and muscle mass 
at 30 days post surgery.   
 
Upon comparing energy and protein intakes within groups at 30 days post surgery with 
those at baseline it could be seen that the intervention group consumed very slightly more 
energy at 30 days post surgery, whereas the control group consumed less at this time, 
however a level of significance was not achieved.  Whilst this could be interpreted that 
when patients are given preoperative carbohydrate loading their energy intake returns to 
their ‘normal’ baseline level quicker, the same cannot be said for protein intakes and more 
interestingly when comparing the percentage of subjects meeting more than 90% of their 
energy and protein requirements at the two time intervals there was no difference seen at 
all.  Therefore it is likely that at 30 days post surgery, preoperative carbohydrate loading is 
no longer having an effect on dietary intake and therefore may disprove the secondary 
aim of the study, although it should always be kept in mind that this may be due to chance 
and if a larger group were studied then more significant results may have been seen.   
 
Wellbeing cannot be compared between the two intervals since the assessment at 
baseline was shortly prior to surgery and therefore not representing a ‘normal’ 
psychological state for subjects (Sutherland, 1952).  Furthermore, subjects at 30 days 
post surgery may still have anxieties regarding their surgery and their recovery, especially 
as at this time point they may not have received the histology results from their surgery 
and therefore may be anxious about whether future treatments are required. 
 
Physical activity data showed that neither group had returned to their baseline activity 
level.  The intervention group were closer to their baseline than the control for each 
parameter suggesting that they may be recovering more quickly however a level of 
statistical significance was not achieved.   Similarly the resting data showed that neither 
group was near to their baseline data, with both taking on average more rest and sleep 30 
days post surgery.  However, again the intervention group was closer to baseline than the 
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control.  It should be considered however that both groups may have been resting more 
following their surgery as patients perceive rest as part of their recovery from surgery..  
 
 4.5  Process outcomes 
 
 
4.5.1 Complications  
 
It was seen that complications were experienced less in the intervention group than the 
control group however this result was not statistically significant, reflecting the results of 
Yuill et al., (2005) and Noblett et al., (2006) where no reductions in complications were 
seen when preoperative carbohydrate loading was given.  This conflicts with Ljungqvist et 
al., 2005 where the results suggested that preoperative carbohydrate loading reduces 
insulin resistance and thus hyperglycaemia, which has previously been shown to 
independently reduce the risk of complications.  
 
Furthermore the rate of infection was lower in the intervention group than the control 
group, though this was not statistically significant either.  Previous research by 
Rasmussen et al., (1985) showed that preoperative carbohydrate loading may improve 
immunity.  This could also be attributed to the reduction in insulin resistance which would 
reduce the cytokine response and thus catabolic effect.  However, this current study does 
not support the work by Rasmussen et al., (1985). 
  
 
4.5.2  POSSUM scores 
 
POSSUM scores also varied between groups, and it was seen the intervention group had 
lower scores for both morbidity and mortality.  Seemingly other studies have not 
investigated whether this treatment directly affects POSSUM scores, however of the 
parameters which are considered when calculating the score, there are only 5 of the 10 
which may be attributed to the stress response.  The remaining parameters, including 
cancer stage, severity of operation, age and mode of surgery, will not be affected by 
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carbohydrate loading.  As the groups were not matched for these parameters then it could 
be argued that comparisons cannot be made between groups for POSSUM scores. 
 
 
4.5.3  Gastrointestinal function 
 
Gastrointestinal function was measured by examining the time taken for stoma to function 
or bowels to open.  There was no difference between the mean length of time for either 
group, however it should be remembered that data was missing for one subject of the 
intervention group.  Previous studies have shown trends towards a quicker return of 
gastrointestinal function when preoperative carbohydrate loading was given (Noblett et al., 
2006 and Henriksen et al., 2003) however these observations were not significant and 
therefore may be due to chance.   
 
 
4.5.4 Length of stay and time on HDU 
 
There was a direction in the data towards a reduction in length of stay in the intervention 
group, which although not statistically significant, may back up previous research (Yuill et 
al., 2005; Ljungqvist, Nygren and Thorell 1998; Noblett et al., 2006).  As insulin resistance 
is linked to length of stay (Thorell et al., 1999) then these findings suggest that 
preoperative carbohydrate loading may reduce the length of hospital stay by reducing 
insulin resistance.  This could potentially have major cost implications for the NHS.  
Currently the average cost of an inpatient bed on a standard surgical ward at SRFT 
stands at £227.  Based on this study whereby 101 patients were eligible within 22 months, 
this means an average of 55 patients per year undergo potentially curative surgery for 
colorectal cancer.  Should these 55 patients see the average reduction in stay of 
approximately four days that was demonstrated in this study then this would save the 
Trust £49940 per year.  Accounting for the cost of the drink, which is currently bought in at 
£5.68 for the three doses per person there is the potential to save an estimated total of 
£49628 annually for this Trust. 
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The time on HDU should also be considered as this was shown to be approximately one 
day less in the intervention group.  This too will have cost implications as within SRFT the 
cost of an HDU bed currently stands at £354, which is £127 more than a bed on a 
standard surgical ward.  Therefore by reducing the stay on HDU this is further reducing 
NHS costs.  In addition to the cost effects, a reduced HDU stay may also have beneficial 
psychological effects for patients.  It is likely that patients see the move from a high 
dependency to a general ward as a large step forward in their recovery and this may 
improve their mental wellbeing.  It is therefore possible that the reduction in HDU care 
may contribute towards a greater wellbeing postoperatively.  Another factor which patients 
report is lack of sleep on the HDU due to noise of machines alarming and the increased 
activity of nursing and medical staff on the ward.   This finding does not correlate with the 
data for hours of sleep, whereby the intervention group had less sleep than the control, 
but these results were an average of the total admission and not just the period of time 
whilst on HDU.  
 
At the time of the final assessment, if there were concerns identified regarding dietary 
intake or weight loss then subjects were given the option to be referred to the dietitian for 
further support.  In total five subjects were considered to be suitable for further dietetic 
monitoring and all accepted the referral.  Of these three were in the control group, 
compared with only one in the intervention group, and whilst it was not possible to analyse 
these due to the small numbers it is possible that this supports the theory of improved 
recovery in those who received preoperative carbohydrate loading. 
 
 
4.6   Recruitment 
 
Poor recruitment to the trial was the primary weakness to this study.   Whilst it was 
originally agreed that 90 participants in each arm, as suggested by the power calculation, 
was in excess of that which one researcher could achieve in the time scale required, it 
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was still not possible to recruit the desired 10 recruits in each arm.  There are several 
factors which may have influenced this: 
 
4.6.1 Sensitivity of the area  
All patients who were invited to partake in the clinical trial had just received a diagnosis of 
cancer.  It was appreciated that this would be likely to have an extreme psychological 
impact on many patients and as such it is possible that involvement in the study may have 
been perceived as an added stress or burden.  Additionally it could be proposed that 
patients may have felt that by receiving an alternative preoperative treatment that their 
outcome could have been adversely affected.  This was addressed in the participant 
information provided at the time of invitation, and it was explained there that would be no 
risk of any detrimental outcome.  However it was also explained that there was a chance 
that their recovery could be improved should they receive the carbohydrate drink.  Seeing 
as preoperative carbohydrate loading is standard practice for all colorectal patients at the 
hospital, potential recruits may have felt that they had a better chance of an improved 
outcome by receiving the standard practice, a guarantee if they were not part of the study. 
 
 
4.6.2 Invitation 
 
In order to avoid bias the principal researcher was unable to invite participants to partake 
in the clinical trial.  It was therefore initially agreed with the colorectal nurses that as they 
see all patients in outpatient clinic with the consultant at the time of diagnosis and upon 
consenting to surgery, then they would provide the invitation during this appointment.  
This however relied upon them providing the invitation to every patient who met the 
eligibility criteria.  The principal researcher also attended the weekly multi-disciplinary 
meeting in which all patients being investigated for colorectal cancer were discussed.   It 
became apparent after two to three months however that occasionally nurses were either 
forgetting to provide the invitation to patients during particularly busy clinics, or selectively 
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choosing not to when patients were particularly upset or deemed by the nurses to be 
inappropriate.   At this time, a specialist ERAS nurse had been recruited within the 
hospital that would be seeing every colorectal patient due for surgery.  It was agreed that 
the ERAS nurse would therefore provide the invitations to patients.  Furthermore it was 
proposed that this arrangement would improve liaisons between the nurse and the 
researcher and also reduce subjective opinion on eligibility.   
 
 
4.6.3  Response times 
 
A further complication was that of the limited time available between diagnosis and 
surgery. National government targets require all patients to be seen by a specialist within 
two weeks of being referred for suspected cancer, and to wait no more than 31 days to 
receive treatment once diagnosis is confirmed (Department of Health, 2009).  Therefore in 
many cases once the decision to undergo surgery had been made, there was then only a 
short time period before their admission which may have been less than a week.  Often 
this was not an adequate timeframe to allow patients to think about the trial and make a 
decision regarding participation.  If they did decide to partake then it took time to send 
back their tear-off slip from the invitation and consent form through the post.  Furthermore, 
the patient then needed to undergo the pre-op assessment a minimum of 3 days prior to 
admission in order to collect baseline data from the Sensewear® armband and food diaries 
at home.  
 
A change in inclusion criteria was approved by the local ethical committee in February 
2009 following an initial slow uptake as it was felt that the number of patients undergoing 
laparoscopic surgery was increasing, and therefore they should be included in order to 
capture a greater number of recruits.  Also this would enable a better reflection of the 
population undergoing potentially curative colorectal surgery for cancer.  However, 
following the change in criteria, only one patient who was recruited underwent 
laparoscopic surgery and therefore this patient was not included in the data analysis due 
75 
 
to differing stress responses between laparoscopic and open surgeries as previously 
explained.   
 
4.7 Potential confounding factors 
 
 
4.7.1  Gender 
 
Research has shown that the cytokine response may vary according to gender, indeed in 
small study (n=25), Ono, Tsujimoto, Hiraki, Takahata,  Kinoshita & Mochizuki (2005) 
showed that cytokine response and surface antigen expression in monocytes were 
significantly higher in females (n=9) than males (n=16) prior to and after surgery for 
gastric carcinoma.   A further study by Schneider, Schwacha and Chaudry (2006) found 
similar results relating to gender in mice models.   This has seemingly not been 
considered in relation to carbohydrate loading, however it could be suggested that if 
women undergo this increased cytokine response then this could therefore further reduce 
their insulin sensitivity.  This is of relevance as gender was not previously considered to 
be a variable in this study and therefore groups were mixed for male and females.  With 
the small number of recruits it was not possible to match the groups for gender and 
therefore it is possible that differences seen may be affected by differing immune 
responses and thus levels of insulin resistance. 
 
4.7.2  Analgesia use 
 
Epidural analgesia is the infusion of localised anaesthesia via a catheter into the epidural 
space (outer part of spinal canal) as a method for pain relief post surgery.  However, it has 
been shown to also reduce insulin resistance as it impedes the release of stress 
hormones, which in turn reduces the hypermetabolic effects seen post surgery (Ljungqvist 
et al., 2005; Uchida, Asoh, Shirasaka & Tsuji, 1988).  Within the present study, groups 
were not matched for epidural use and therefore this may have affected insulin resistance 
and thus their post-operative recovery.  
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Furthermore, opioid use was not monitored and this may have affected dietary intake due 
to its effect on gastric and gut motility (Ljungqvist et al., 2005).   
 
 
4.7.3  Cancer stage 
 
Cancer stage may be a confounding factor for this study as groups were not matched for 
this.  It is evident that those patients with tumour invasion and metastasis are likely to be 
more stressed as tumour growth results in increased REE (Hyltander et al 1991).  It would 
therefore be expected that those patients with larger tumours and metastasis (stages II to 
IV) would have a higher metabolic rate than those of stage I.  Indeed Cao et al (2010) 
demonstrated those patients with stage IV cancer had a higher REE than those with 
stages I-III.   
 
4.7.4 Length of surgery 
 
Within this study the groups were not matched for length of surgery, and this has been 
shown to independently affect insulin sensitivity (Thorell et al., 1993).  It is therefore 
possible that the trends seen and believed to be due the preoperative carbohydrate 
loading may have also been affected by varying insulin sensitivities as a result of different 
surgery durations.  On reflection it would have been advantageous to gather data from the 
surgery notes on duration of surgery in order to conclude whether this may have been a 
confounding factor.  
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5.  Conclusions 
 
This study set out to test the hypothesis that preoperative carbohydrate loading results in 
longer term improvements in wellbeing, sustained return of postoperative physical function 
and better retention of muscle mass and nutritional status. 
 
Overall the data suggested that there was no effect of preoperative carbohydrate loading 
seen in any parameter with the exception of pain (table 25).  All values from statistical 
analysis, with the exception of pain at 30 days post surgery were >0.1 and therefore no 
trends were seen.  It is likely that this was due to the small sample size, which was 
considerably lower than that required by the power calculation.  
 
 Outcomes Objectives Hypotheses Hypothesis 
supported (9) or 
not supported (x) 
Main aim To investigate the long-term effects of preoperative 
carbohydrate loading on colorectal patients  
 
Primary Weight and 
anthropometry  
as a measure of 
nutritional status 
To investigate 
whether 
carbohydrate 
loading affects 
changes in 
weight and 
anthropometry 
from pre-op to 
30 days post 
surgery 
Carbohydrate 
loading results in 
better retention of 
weight and muscle 
mass at 30 days 
post surgery. 
 
 
x 
Secondary Nutritional intake 
as a measure of 
nutritional status.
To investigate 
whether 
carbohydrate 
loading affects 
nutritional intake 
post-operatively. 
 
Carbohydrate 
loading improves 
nutritional intake 
and status 
immediately post-
surgery and at 30 
days post surgery. 
Immediately post 
surgery: x 
 
30 days post 
surgery: 
x 
Other 
outcomes 
Relationship 
between 
carbohydrate 
loading and 
wellbeing. 
 
 
 
 
 
To investigate 
whether 
carbohydrate 
loading affects 
wellbeing and 
pain scores pre-
operatively up to 
30 days post 
surgery.  
 
Carbohydrate 
loading results in 
short and longer 
term improvements 
in wellbeing. 
 
 
 
 
 
 
x 
 
 
Pain at 30 days 
post surgery: 9 
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Time spent on a 
high 
dependency unit 
(HDU) and 
overall length of 
stay in hospital. 
 
 
 
Activity levels as 
a measure of 
physical function 
 
To investigate 
whether 
carbohydrate 
loading affects 
the number of 
days spent on 
HDU and length 
of stay. 
 
To investigate 
whether 
carbohydrate 
loading affects 
physical activity 
levels. 
Carbohydrate 
loading reduces 
length of time spent 
on HDU and overall 
length of stay.  
 
 
 
 
Carbohydrate 
loading results in 
improved return of 
physical function 
post surgery. 
 
 
 
 
x 
 
 
 
 
x 
 
Table 25.  Summary of study outcomes related to proposed hypotheses. 
 
6.   Future research 
This pilot study certainly warrants further research and clearly this would need to include a 
larger sample size.   Although only one significant result was found, there were 
differences seen between groups and it is possible that with a larger sample some 
significant findings could be seen, with potential consequences for clinical practice.  It 
would also be interesting to examine the effects for longer than 30 days, as the significant 
increased pain in the control group was seen at 30 days post surgery and therefore the 
effects of preoperative carbohydrate loading may last further past this time point.   A 
further suggestion would be to reduce the number of aims studied in future research in 
order to reduce the chance of results being due to other variables.   
 
9. Implications for practice 
The results of this study could have been beneficial to the NHS if positive, for example 
cost savings could be made, and the patient journey improved.  This could also impact on 
dietetic referrals as it is possible that carbohydrate loading may improve nutritional intake 
post surgery.  Furthermore, it is possible that these findings could also be extrapolated, or 
suggest future research opportunities for other surgical areas, for example elective 
orthopaedics or gynaecology.  A further possibility is to consider the option of increasing 
the dose of carbohydrate given, considering that this may enhance the effects of improved 
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recovery.  However a larger dose may affect osmolality and therefore gastric emptying, 
making it unsafe to use.  
 
Aside from the clinical findings of this study, what is also relevant is that through carrying 
out this comprehensive research study an appreciation has been attained of the difficulty 
of undertaking research.  The poor recruitment rates and other difficulties were not 
expected and demonstrated why larger scale studies take place over such a long time 
scale and require so many investigators.  Indeed, it also highlights the importance of 
interpreting other studies with caution and thoroughly examining research methods and 
confounding factors before accepting the findings of the study.  
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Appendix 1 
Sample Size Calculation Information 
1. Variables of interest (type of data): 
• Weight (Continuous) 
• Body mass index (Continuous) 
• Mid Arm Muscle Circumference (Continuous) 
• Well-being (Measured using Visual Analogue Scale) (Continuous) 
i. Hunger 
ii. Thirst 
iii. Tiredness 
iv. Nausea 
v. Anxiety 
 
2. The desired power 
80%  
3. The desired significance level 
P<0.05 
4. The effect size of clinical importance 
• Weight:  -10% 
• Arm Muscle Circumference (AMC) : loss of muscle mass, indicated by 
change in AMC from baseline to discharge, was significantly greater in the 
control group (control -1.1+0.15 cm; carbohydrate drink -0.5+0.16 cm, 
P<0.05, t-test) (Yuill et al., 2005, p 35) 
• VAS: Unable to use in calculation as rank not ratio data 
 
5. Mean and Standard deviation of continuous outcome variables (based on 
prior studies) 
Arm Muscle Circumference (Bishop et al., 1981)  
 AMC 50th centile SD AMC* 
Males 45-54 y 28.1 cm 2.2 
Males 55-64 y 27.9 cm 1.75 
Females 45-54 y 22.2 cm 2.2 
Females 55-64 y 22.6 cm 2.53 
• The approximate SD had to be estimated from Mid arm circumference and triceps 
skinfold data (Frisancho AR, 1990) as Bishop et al. (1981) did not publish SDs.   
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Weight (kg) Frisancho (1990) 
 Mean Weight  SD 
Males 45-49.9 y 80.8 kg 14 
Males 50-54.9 y 79.5 kg 13.9 
Males 55-59.9 y 79.4 kg 13.9 
Males 60-64.9 y 77.3 kg 13.1 
Females 45-49.9 y 68.2 kg 16.3 
Females 50-54.9 y 68.3 kg 14.8 
Females 55-59.9 y 69.2 kg 16.3 
Females 60-64.9 y 68.0 kg 14.2 
 
6. One- or two-sided tests 
Two sided test 
7. Design of the study:  
• randomised controlled trial  
• includes repeated measures 
• groups of approximately equal size 
SAMPLE SIZE CALULATIONS 
Weight Based Calculations 
 
Group N per group 
(independent 
measures) 
N per group (repeated 
measures) 
Males 45-49.9 y 48 26 
Males 50-54.9 y 48 26 
Males 55-59.9 y 49 26 
Males 60-64.9 y 46 25 
Females 45-49.9 y 90 ? 
Females 50-54.9 y 74 ? 
Females 55-59.9 y 88 ? 
Females 60-64.9 y 69 ? 
 
Arm muscle circumference based calculations 
 
Group Number required per 
group (repeated 
measures)* 
Males 45-54 y 34 
Males 55-64 y 34 
Females 45-54 y 49 
Females 55-64 y 49 
*Unable to calculate estimates of number required to detect a difference between 
independent groups as required data not available. 
 
 
Summary  
 
To detect a 10% difference in weight between groups of males with 80% power at 0.05 
level of significance we will need approximately 50 per group.  Due to greater variation in 
weight in women we would need approximately 90 per group.  For arm muscle 
circumference, to detect a change of 1.1 cm within a group we would need approximately 
34 per groups for males (45-54 y) or (55-64 y).  For women we would need 49 (for 45-54 
y) or (55-64 Y). 
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Appendix 2:   Ethics approval •  
National Research Ethics 
Service  
Salford & Trafford Local Research Ethics 
Committee  
Room 181  
Gateway House  
Piccadilly South  
Manchester  
M607LP  
Telephone: 0161  2372438  
Facsimile: 0161 2372383  
19 November 2007  
Miss Claire Beadman  
Dietitian  
 
Dear Miss Beadman  
 
Full title of study:  
Randomised control trial investigating the long term  
effects of preoperative carbohydrate-loading for  
colorectal surgical patients.  
REC reference number:  
07/H1004/147  
 
Thank you for your letter of 14 November 2007, responding to the Committee's request for 
further information on the above research and submitting revised documentation.  
The further information has been considered on behalf of the Committee by Ms Beverly 
Harrison, qualitative expert member of the Committee in place of Mrs Janet Marsden,Vice- 
Chair, who is currently out of the country ..  
Confirmation of ethical opinion  
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised.  
Ethical review of research sites  
The Committee has designated this study as exempt from site-specific assessment (SSA). 
There is no requirement for [other] Local Research Ethics Committees to be informed or for 
site-specific assessment to be carried out at each site.  
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Conditions of approval  
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document. You are advised to study the conditions carefully.  
Approved documents  
The final list of documents reviewed and approved by the Committee is as follows: 
 
Document 
  
Date  
  Version  
Application    5.4 03 September  
    2007  
Investigator CV      
Protocol    1  03 September  
    2007  
Covering Letter     15 August 2007 
Summary/Synopsis   1  03 September  
    2007  
Questionnaire: Assessment of well being  2  22 October 2007 
Letter of invitation to participant   2  22 October 2007 
Participant Information Sheet   2  22 October 2007 
Participant Consent Form      2 22 October 2007 
Response to Request for Further Information   14 November  
    2007  
Sponsor Signature     25 September  
    2007  
CV - Kirstine Farrar - Educational Supervisor   21 September  
    2007  
  
R&D approval  
 
 
 
 
 
 
 
 
 
 
 
 
All researchers and research collaborators who will be participating in the research at NHS  
sites should apply for R&D approval from the relevant care organisation, if they have not yet  
done so. R&D approval is required, whether or not the study is exempt from SSA. You  
should advise researchers and local collaborators accordingly.  
Guidance on applying for R&D approval is available from  
http://www.rdforum.nhs.uklrdform.htm. 
Statement of compliance  
The Committee is constituted in accordance with the Governance Arrangements for  
Research Ethics Committees (July 2001) and complies fully with the Standard Operating  
Procedures for Research Ethics Committees in the UK.  
 
After ethical review  
Now that you have completed the application process please visit the National Research  
Ethics Website > After Review  
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Here you will find links to the following  
a)  Providing feedback. You are invited to give your view of the service that you have   
received from the National Research Ethics Service on the application procedure. If  
you wish to make your views known please use the feedback form available on the  
website.  
b)  Progress Reports. Please refer to the attached Standard conditions of approval by  
Research Ethics Committees.  
c)  Safety Reports. Please refer to the attached Standard conditions of approval by  
Research Ethics Committees.  
d)  Amendments. Please refer to the attached Standard conditions of approval by  
Research Ethics Committees.  
e)  End of Study/Project. Please refer to the attached Standard conditions of approval  
by Research Ethics Committees.  
We would also like to inform you that we consult regularly with stakeholders to improve our  
service. If you would like to join our Reference Group please email  
referencegroup@nationalres.org.uk 
  
se quote this number on all corresponde 
Nutritional Composition of PreLoad 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With the Committee's best wishes for the success of this project  
Yours sincerely   
Mrs Janet Marsden  
Vice-Chair, Salford and Trafford REC  
Email: maggie.twiney@northwest.nhs.uk  
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Appendix 3 
 
Nutritional Composition of PreLoad© 
 
 
Composition of 50g sachet of dry Powder 
 
 
Energy    kcal    190 
       kJ    805 
 
Protein g     nil 
 
Carbohydrate g    48 
   
Fat g      nil 
 
Sodium   mg    <15 
                  mmol    <1 
 
Potassium mg    <2 
                     mmol    <0.1 
   
Chloride   mg    <20 
                    mmol                                   <0.6 
 
Osmolality      120mOsm/kgH20/litre 
Osmolarity                285mOsm 
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Appendix 4  
(Based on tool used by Hausel et al, 2001) 
 
Assessment of well-being.  
 
 
Please mark on each scale how you are currently feeling for each factor. 
 
How anxious are you feeling at present? 
 
 
 
Not at all anxious       Extremely anxious 
 
 
 
How would your rate your depression at the moment? 
 
 
 
Not at all depressed       Extremely depressed 
 
  
 
How would you describe your hunger at present? 
 
 
 
Not at all hungry       Extremely hungry 
 
 
 
How would you rate your ability to concentrate? 
 
 
 
Fully able to concentrate      Unable to concentrate 
 
 
 
How would you rate your general feeling of bodily discomfort at present? 
 
 
 
Feeling generally well      Feeling generally very unwell 
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Are you suffering any feeling of sickness at the moment? 
 
 
 
No feeling of sickness at all    Feel extremely sick 
 
 
 
 
Are you in any pain at the moment? 
 
 
 
No pain at all       Very severe pain 
 
 
 
 
Please rate your thirst at the present time 
 
 
 
Not at all thirsty       Extremely thirsty 
 
 
 
 
How tired are you feeling at present?  
 
 
 
Not at all tired       Extremely tired 
 
 
 
 
Please rate your feeling of fitness at the moment 
 
 
 
No feeling of unfitness at all     Extremely unfit 
 
 
 
 
Are you feeling weak at the moment? 
 
 
 
No feeling of weakness at all     Extremely weak 
93 
 
 
 
Appendix 5 
(Based on tool used by Hausel et al, 2001) 
 
Assessment of Pain 
 
 
Please mark on each scale the pain that you currently experience for each of the following 
activities. 
 
 
 
At rest 
 
 
 
 Pain free        Intense pain 
 
 
 
 
Standing up beside the bed 
 
 
 
 
             Pain free         Intense pain 
 
 
 
 
Coughing 
 
 
 
 
               Pain free                               Intense pain 
 
 
 
 
 
When moving around 
 
 
 
 
           Pain free                           Intense pain 
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Appendix 6.  POSSUM score calculation 
Taken from Pratt, Joseph, Callery and Vollmer (2008) 
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